Victor-Hugo González-Cardenas

Prof. Dr. Victor-Hugo González-Cardenas

Anesthesiology Resuscitation and Pain Therapy, Hospital Universitari de Girona Doctor Josep Trueta, Girona, Catalonia, Spain
+1
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in Minerva Anestesiologica
Verified
Journal Article
Closed access
EVEduardo Vega
Eduardo Vega
YBYves Beaulieu
Yves Beaulieu
RGRachel Gauvin
Rachel Gauvin
CFCatherine Ferland
Catherine Ferland
SSStephanie Stabile
Stephanie Stabile
PIPablo Mauricio Ingelmo
Pablo Mauricio Ingelmo
Chronic non-cancer pain in children and adolescents has been described as "a modern public health disaster" that has generated significant medical and economic burdens within society. Seen as a disease in its own right, chronic pain has short and long-term consequences that impact not only the patient's health but also that of friends and families, due to significant parenting stress and disruptions in family life and structure. The evidence supporting pharmacological treatments and interventional procedures is limited, and no single strategy has been shown to be completely effective in children with chronic non-cancer pain. Therefore, considering the multifactorial nature of chronic pain, these patients should be treated with a multidisciplinary, balanced approach that seeks a primary outcome of improved functioning rather than of pain reduction. Using a bio-psycho-social approach, a multidisciplinary team, including a physiotherapist, nurse, social worker, psychologist, and physician, has been effective in achieving this outcome of improved functioning in children and adolescents with chronic pain. In this review, we discuss the impact, associated conditions, and evolution of chronic pain, along with the crucial role of every member of a multidisciplinary chronic pain clinic involved in the care of the children and adolescents with chronic non-cancer pain.

3 June 2021 in Pain Reports
Verified
Journal Article
Open access
CMCarolina B. Meloto
Carolina B. Meloto
PIPablo Mauricio Ingelmo
Pablo Mauricio Ingelmo
EPEduardo Vega Perez
Eduardo Vega Perez
RPRebecca Pitt
Rebecca Pitt
Victor-Hugo González-CardenasVictor-Hugo González-Cardenas
Victor-Hugo González-Cardenas
LDLuda Diatchenko
Luda Diatchenko
Introduction: Mast cell (MC) activation could establish a positive feedback loop that perpetuates inflammation and maintains pain. Stabilizing MCs with ketotifen fumarate (KF) may disrupt this loop and relieve pain. Objective: We aimed to test the effect of treatment with KF in pain assays in mice and in a case series of patients with chronic widespread pain. Methods: The analgesic effect of KF was tested in CD-1 mice injected with formalin, complete Freund's adjuvant, or subjected to spared nerve injury. In addition, wild-type (C57BL/6) and MC-deficient (C57BL/6-Kit W-sh/W-sh) mice were injected with formalin or complete Freund's adjuvant and treated with KF. Patients with chronic widespread pain (n = 5; age: 13–16 years) who failed to respond to standard of care participated in a 16-week treatment trial with KF (6 mg/d). Ketotifen fumarate's therapeutic effect was evaluated using the patient global impression of change. Results: In the mouse experiments, KF produced dose- and MC-dependent analgesic effects against mechanical allodynia in the acute and chronic inflammatory pain but not neuropathic pain assays. In the patient case series, 4 patients reported that activity limitations, symptoms, emotions, and overall quality of life related to their pain condition were “better” or “a great deal better” since beginning treatment with KF. This was accompanied by improvements in pain comorbid symptoms. Conclusion: Treatment with KF is capable of reducing established inflammatory-induced mechanical nociception in an MC-dependent manner in mice, and it may be beneficial for the treatment of chronic pain conditions.

29 January 2025 in European journal of pain
Verified
Journal Article
Closed access
Victor-Hugo González-CardenasVictor-Hugo González-Cardenas
Victor-Hugo González-Cardenas
MDMariafernanda Valdivieso Díaz
Mariafernanda Valdivieso Díaz
CACarlos Felipe Mateus Almeciga
Carlos Felipe Mateus Almeciga
JCJuan Carlos Echeverry Carrillo
Juan Carlos Echeverry Carrillo
JTJuan Carlos López Trujillo
Juan Carlos López Trujillo
JRJorge Luis Paternina Rojas
Jorge Luis Paternina Rojas

1 April 2018 in Colombian Journal of Anesthesiology
Verified
Journal Article
Open access
Victor-Hugo González-CardenasVictor-Hugo González-Cardenas
Victor-Hugo González-Cardenas
FMFredy Danilo Munar-González
Fredy Danilo Munar-González
IPIgor Leonardo Pinzón-Villazon
Igor Leonardo Pinzón-Villazon
SCSergio Hernando Cabarique-Serrano
Sergio Hernando Cabarique-Serrano
CBClaudia Cecilia Burbano-Paredes
Claudia Cecilia Burbano-Paredes
VMVictor Daniel Meneses
Victor Daniel Meneses
Introduction: Postoperative delirium is not only an outcome of unknown precise incidence in pediatrics but also a controversial field for pediatric anesthesiology. Objective: To estimate the incidence of postoperative pediatric delirium in low surgical risk procedures and to analyze risk factors (such as acute postoperative pain). Materials and methodology: Prospective analytical observational study of incident cohort that included patients between 2 and 10 years of age, American Society of Anesthesiology I to II, undergoing low-risk surgery. Sample size: probable incidence 33%, accuracy 5%, confidence 95%, n = 340 patients. Sequential sample selection was done after admission to the operating room. Concurrent and longitudinal follow-up was carried out. Results: Incidence of delirium was 13.2%. A strong relationship was found between the presence of severe acute postoperative pain and delirium. Dexamethasone was a risk factor. A high association was found between remifentanil and severe acute postoperative pain. Conclusions: A low incidence of delirium was found as compared with other reports in the world literature. The diagnostic strength of the scales used is controversial because of the similarities between measurement parameters. Scientific evidence that challenges the use of dexamethasone as a triggering factor is offered. A direct association between pain and delirium is found, and it is even argued that the use of remifentanil could favor the presence of severe acute postoperative pain (hyperalgesia). Resumen Introducción: El Delirium postoperatorio no sólo es un desenlace del que se desconoce una incidencia precisa en pacientes pediátricos, también es un campo controvertido para la Anestesiología Pediátrica. Objetivo: Calcular la incidencia de Delirium Pediátrico Postoperatorio en cirugías de bajo riesgo quirúrgico y analizar factores de riesgo,(Como el dolor agudo postoperatorio). Materiales y método: Estudio Observacional Prospectivo Analítico de Cohorte Incidente. Incluyó pacientes entre 2 y 10 años, ASA I-II, sometidos a cirugías de bajo riesgo quirúrgico. Tamaño de Muestra: Incidencia probable=33%, Precisión=5%, Confianza95%, n = 340 pacientes. Selección muestral secuencial al ingreso a salas de cirugía. Seguimiento concurrente y longitudinal. Resultados: Incidencia de Delirium=13,2%. Se encontró una fuerte relación entre Dolor Agudo Postoperatorio Severo y Delirium. La Dexametasona se comportó como un factor de riesgo. Remifentanyl presentó una alta asociación con Dolor Agudo Severo Postoperatorio. Conclusiones: Se encontró una incidencia de Delirium pediátrico baja con respecto a otros reportes a nivel mundial. Se controvierte la fortaleza diagnóstica de las escalas empleadas dadas las similitudes en sus parámetros de medición. Se aporta evidencia científica que debate el empleo de Dexametasona como inductor de Delirium. Se asocia de manera directa la presencia de Dolor y Delirium, e incluso se argumenta cómo el empleo de Remifentanyl podría facilitar la presencia de Dolor Agudo Severo Postoperatorio (Hiperalgesia).

18 July 2021 in Children
Verified
Journal Article
Open access
PDF file
MKMegan Kouri
Megan Kouri
MSMarta Somaini
Marta Somaini
Victor-Hugo González-CardenasVictor-Hugo González-Cardenas
Victor-Hugo González-Cardenas
KNKacper Niburski
Kacper Niburski
MVMarie Vigouroux
Marie Vigouroux
PIPablo Mauricio Ingelmo
Pablo Mauricio Ingelmo
Chronic headaches are a major source of morbidity in the pediatric population, affecting physical function, school attendance, social capacity, mood, and sleep. In adults, repetitive sphenopalatine ganglion (SPG) blockade has been studied as a preventive treatment for chronic migraines. This case series aims to evaluate the SPG block for the preventive treatment of chronic daily headache (CDH) in adolescents. We prospectively evaluated 17 adolescents (14 females, 14 ± 1 year) with CDH not responding to cognitive behavioral therapy (CBT), physiotherapy, and standard medications. Each patient received 10 SPG blocks (two blocks/week) using the Tx360® device. At the end of treatment, 10 patients (59%) reported a Patient’s Global Impression of Change (PGIC) score ≥ 67%, and 3 months after the end of treatment, nine patients (53%) sustained a PGIC ≥ 67%. There was also a statistically significant reduction in the depression subscale of the Revised Children’s Anxiety and Depression Scale (RCADS) at the end of treatment and 3 months post-treatment compared with baseline. The procedure was well tolerated with no adverse effects. In our study, the use of repeat SPG blockade was associated with sustained benefits on the PGIC and the depression subscale of the RCADS when used as preventive headache treatment in adolescents with refractory CDH.

17 June 2022 in Canadian Journal of Pain
Verified
Journal Article
Open access
MSMichelle Stoopler
Michelle Stoopler
MCManon Choinière
Manon Choinière
ANAnnabelle Nam
Annabelle Nam
AGAndré Guigui
André Guigui
LWLaurel Walfish
Laurel Walfish
PIPablo Mauricio Ingelmo
Pablo Mauricio Ingelmo
There is limited information regarding the effects of pediatric chronic pain management on the number and cost of chronic pain–related emergency department (ED) consultations.This retrospective stu... Contexte : L'information sur les effets de la prise en charge de la douleur chronique pédiatrique sur le nombre et le coût des consultations liées à la douleur chronique au service des urgences est...